![](https://scx1.b-cdn.net/csz/news/tmb/2022/pfizer-reported-2021-a.jpg)
Pfizer sees Covid-19 drug sales topping $50 bn in 2022
Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.
Feb 8, 2022
0
6